Literature DB >> 7567218

The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

M R Pierce1, E Bancalari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567218     DOI: 10.1002/ppul.1950190611

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


× No keyword cloud information.
  17 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 3.  Dexamethasone therapy in chronic lung disease.

Authors:  S Sardesai; M Durand
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

4.  The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation.

Authors:  Joo Yun Yang; Jihei Cha; So-Yeon Shim; Su Jin Cho; Eun Ae Park
Journal:  Korean J Pediatr       Date:  2014-04-30

Review 5.  Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

Authors:  Wes Onland; Martin Offringa; Anton van Kaam
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

Review 6.  Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-11-28

7.  NICU bedside caregivers sustain process improvement and decrease incidence of bronchopulmonary dysplasia in infants < 30 weeks gestation.

Authors:  Sara J Mola; David J Annibale; Carol L Wagner; Thomas C Hulsey; Sarah N Taylor
Journal:  Respir Care       Date:  2014-11-25       Impact factor: 2.258

8.  Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages.

Authors:  Y H Li; Z Q Yan; J S Jensen; K Tullus; A Brauner
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 9.  Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.

Authors:  Vibhuti S Shah; Arne Ohlsson; Henry L Halliday; Michael Dunn
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

10.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.